Clinical Trial

Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing Type 2 Diabetes

Completed
View on ClinicalTrials.gov →
Summary
Use of continuous glucose monitor (CGM) in post kidney transplant patients to better assess changes in glucose levels post kidney transplant
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-26.
Status change: Active, Not Recruiting → Completed 2026-02-20
Trial Details
NCT Number NCT07271433
Lead Sponsor The Cleveland Clinic
Collaborators: Abbott Medical Devices
Conditions Kidney Transplant
Enrollment 20 participants
Start Date 2024-01-29
Primary Completion 2024-11-12 (estimated)
Study Completion 2026-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-23